Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Progerin affects cell shape but not hair or skin in mice.

Laser hair removal works well for people with dark hair and light skin, but it's less effective for light hair or dark skin; improvements are expected.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Human skin can make serotonin and melatonin.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.